spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Graves, T. K.
Right arrow Articles by Hinkle, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Graves, T. K.
Right arrow Articles by Hinkle, P. M.
Journal of Cell Science 114, 3685-3694 (2001)
© 2001 The Company of Biologists Limited


RESEARCH ARTICLE

Misfolded growth hormone causes fragmentation of the Golgi apparatus and disrupts endoplasmic reticulum-to-Golgi traffic

Thomas K. Graves1, Shilpa Patel2, Priscilla S. Dannies2 and Patricia M. Hinkle1,*

1 Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
2 Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06510, USA

*Author for correspondence (patricia_hinkle{at}urmc.rochester.edu)

Accepted July 9, 2001

In some individuals with autosomal dominant isolated growth hormone deficiency, one copy of growth hormone lacks amino acids 32-71 and is severely misfolded. We transfected COS7 cells with either wild-type human growth hormone or {Delta}32-71 growth hormone and investigated subcellular localization of growth hormone and other proteins. {Delta}32-71 growth hormone was retained in the endoplasmic reticulum, whereas wild-type hormone accumulated in the Golgi apparatus. When cells transfected with wild-type or {Delta}32-71 growth hormone were dually stained for growth hormone and the Golgi markers ß-COP, membrin or 58K, wild-type growth hormone was colocalized with the Golgi markers, but ß-COP, membrin and 58K immunoreactivity was highly dispersed or undetectable in cells expressing {Delta}32-71 growth hormone. Examination of {alpha}-tubulin immunostaining showed that the cytoplasmic microtubular arrangement was normal in cells expressing wild-type growth hormone, but microtubule-organizing centers were absent in nearly all cells expressing {Delta}32-71 growth hormone. To determine whether {Delta}32-71 growth hormone would alter trafficking of a plasma membrane protein, we cotransfected the cells with the thyrotropin-releasing hormone (TRH) receptor and either wild-type or {Delta}32-71 growth hormone. Cells expressing {Delta}32-71 growth hormone, unlike those expressing wild-type growth hormone, failed to show normal TRH receptor localization or binding. Expression of {Delta}32-71 growth hormone also disrupted the trafficking of two secretory proteins, prolactin and secreted alkaline phosphatase. {Delta}32-71 growth hormone only weakly elicited the unfolded protein response as indicated by induction of BiP mRNA. Pharmacological induction of the unfolded protein response partially prevented deletion mutant-induced Golgi fragmentation and partially restored normal TRH receptor trafficking. The ability of some misfolded proteins to block endoplasmic reticulum-to-Golgi traffic may explain their toxic effects on host cells and suggests possible strategies for therapeutic interventions.

Key words: Golgi apparatus, Growth hormone, Unfolded protein response




This article has been cited by other articles:


Home page
EndocrinologyHome page
L. McGuinness, C. Magoulas, A. K. Sesay, K. Mathers, D. Carmignac, J.-B. Manneville, H. Christian, J. A. Phillips III, and I. C. A. F. Robinson
Autosomal Dominant Growth Hormone Deficiency Disrupts Secretory Vesicles in Vitro and in Vivo in Transgenic Mice
Endocrinology, February 1, 2003; 144(2): 720 - 731.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2001